Active Funding Opportunity Announcements (FOAs) for All NICHD
NICHD issues and participates in various FOAs to support research activities and training.
Investigator-Initiated (Unsolicited) Projects
To submit unsolicited or investigator-initiated applications, use the appropriate NIH Parent Announcement.
Active FOAs for NICHD
Please note: The following FOAs are sorted by date, from most recent to oldest. Select a table heading to change how to sort and display the FOAs.
| Announcement Number | Submissions Date(s) | Expiration Date | Activity Code(s) | Title |
|---|---|---|---|---|
| RFA-MH-19-136 | September 27, 2018; September 6, 2019; September 9,2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. |
September 10, 2020 | R01 | BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) |
| PAR-18-766 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
September 8, 2021 | R01 | Identification and Management of Behavioral Symptoms and Mental Health Conditions in Individuals with Intellectual Disabilities (R01 - Clinical Trial Optional) |
| RFA-NS-18-030 | July 3, 2018; N?o?v?e?m?b?e?r? ?6, 2018; July 3, 2019; November 6, 2019; July 1, 2020; November 10, 2020by 5:00 PM local time of applicant organization.All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | November 11, 2020 | R01 | BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed) |
| PAR-18-745 | June 14, 2018, November 14, 2018, June 14, 2019, November 14, 2019, June 15, 2020 and November 13, 2020 by 5:00 PM local time of applicant organization. | November 14, 2020 | R21 | Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional) |
| PAR-18-747 | June 14, 2018, November 14, 2018, June 14, 2019, November 14, 2019, June 15, 2020, November 13, 2020 by 5:00 PM local time of applicant organization. | November 14, 2020 | R01 | Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional) |
| PA-18-728 | Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
January 8, 2021 | R21 | Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional) |
| PA-18-729 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
January 8, 2021 | R01 | Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional) |
| PA-18-720 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | May 8, 2021 | R21 | Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional) |
| PAR-18-714 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | May 8, 2021 | R15 | Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) |
| RFA-NS-18-019 | May 15, 2018, November 27, 2018, May 1, 2019, October 29, 2019, May 1, 2020, and October 29, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
October 30, 2020 | U01 | BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01-Clinical Trials Not Allowed) |
| RFA-NS-18-020 | May 15, 2018, November 27, 2018, May 1, 2019, October 29, 2019, May 1, 2020, and October 29, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
October 30, 2020 | R01 | BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (R01 Clinical Trials Not Allowed) |
| RFA-EY-18-001 | May 1, 2018, November 27, 2018, May 1, 2019, October 29, 2019, May 1, 2020, and October 29, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
October 30, 2020 | R21 | BRAIN Initiative: New Concepts and Early - Stage Research for Large - Scale Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) |
| PA-18-688 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | May 8, 2021 | R01 | Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R01 Clinical Trial Optional) |
| PAR-18-691 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | May 8, 2021 | R21 | Innovative Therapies and Tools for Screenable Disorders (R21 Clinical Trial Optional) |
| PAR-18-689 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | May 8, 2021 | R01 | Innovative Therapies and Tools for Screenable Disorders (R01 Clinical Trial Optional) |
| PA-18-687 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | May 8, 2021 | R03 | Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R03 Clinical Trial Optional) |
| PAR-18-690 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | May 8, 2021 | R03 | Innovative Therapies and Tools for Screenable Disorders (R03 Clinical Trial Optional) |
| PA-18-648 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | January 8, 2021 | R13 | NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) |
| PA-18-589 | A successor-in-interest request must be made before the anticipated start date at the new organization and preferably several months in advance. | January 26, 2021 | 666 | Successor-in-Interest (Type 6 Parent Clinical Trial Optional) |
| PA-18-590 | A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance. | January 26, 2021 | 777 | Change of Grantee Organization (Type 7 Parent Clinical Trial Optional) |
BACK TO TOP